GSK Diversification Pays Off With 21% Growth In Asia Pacific Sales: Emerging Markets Earnings Round Up (Part 1)

GlaxoSmithKline PLC April 27 released its first quarter results showing a handsome payoff for a diversification policy the pharmaceutical giant implemented three years ago. Although GSK overall sales declined 11%, strong growth in emerging markets and Japan helped offset losses from key products and bolster the net profit up by 14%.